Global Trust Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-20
Closed -$1.26K – 476
2026
Q1
$1.26K Hold
20
– – ﹤0.01% 429
2025
Q4
$1.33K Sell
20
-1,050
-98% -$67.9K ﹤0.01% 422
2025
Q3
$72K Sell
1,070
-565
-35% -$44.7K 0.03% 254
2025
Q2
$143K Buy
+1,635
New +$128K 0.08% 184
2023
Q1
– Sell
-160
Closed -$18.1K – 434
2022
Q4
$18.1K Buy
+160
New +$17.6K 0.01% 273
2020
Q2
– Sell
-4,000
Closed -$278K – 350
2020
Q1
$278K Buy
+4,000
New +$249K 0.22% 115

Other funds holding DXCM

Global Trust Asset Management's DXCM Position: Q2 2026 in Review

Global Trust Asset Management sold out of DexCom (DXCM) in Q2 2026, closing a stake of 20 shares — an estimated $1.26K sold.

Global Trust Asset Management first reported a position in DXCM in Q1 2020 and held it in 6 quarters. The position peaked at $278K in Q1 2020. 976 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Global Trust Asset Management reported no remaining DexCom position as of Q2 2026 after selling out during the quarter.
  • Global Trust Asset Management sold 20 DexCom shares in Q2 2026, an estimated $1.26K.
  • Global Trust Asset Management first reported a position in DexCom in Q1 2020 and held it in 6 quarters.
  • Global Trust Asset Management's DexCom position peaked at $278K in Q1 2020.
  • 976 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Global Trust Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.